• Ultragenyx granted 45,984 restricted stock units to 23 newly hired non-executive officers, with a grant date of Aug. 16, 2026.
• RSUs vest over four years, with 25% vesting on each anniversary of the grant date, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief on August 25, 2026, and is solely responsible for the information contained therein.